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Abstract
Alzheimer's disease (AD), the most common form of dementia among the elderly, manifests 
mostly late in adult life. However, it is presently unclear when the disease process starts and how 
long the pathobiochemical processes take to develop. Our goal is to address the timing and nature 
of triggers that lead to AD. To explain the etiology of AD, we have recently proposed a “Latent 
Early Associated Regulation” (LEARn) model, which postulates a latent expression of specific 
genes triggered at the developmental stage. This model integrates both the neuropathological 
features (e.g., amyloid-loaded plaques and tau-laden tangles) and environmental factors (e.g., diet, 
metal exposure, and hormones) associated with the disease. Environmental agents perturb gene 
regulation in a long-term fashion, beginning at early developmental stages, but these perturbations 
do not have pathological results until significantly later in life. The LEARn model operates 
through the regulatory region (promoter) of the gene and by affecting the methylation status within 
the promoter of specific genes.
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Neurochemical characteristics of Alzheimer's disease
The major symptoms of Alzheimer's disease (AD) include severe loss of memory, cognition, 
reasoning, and other intellectual abilities, and it is the most prominent form of dementia 
among the elderly in Western countries (Hebert et al. 2003). At the neuropathological level, 
the disease is characterized by excessive deposition of two major proteinaceous aggregates. 
They are hyperphosphorylated microtubule associated protein τ “tangles” and senile plaques 
formed mostly of the amyloid-β peptide (Aβ), which is derived from the β-amyloid precursor 
protein (APP). These two protein aggregates are the basis for the two currently-dominant 
models in the field, the “amyloid hypothesis” and the “τ hypothesis” (Sambamurti et al. 
2006). According to the “amyloid model”, the neurotoxicity of Aβ dimers and oligomers 
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and/or damage caused by Aβ plaque aggregation as the primary cause of AD. The “τ model” 
suggest that aggregation of hyperphosphorylated τ leads to neuronal cell death and resulting 
neuropathology. Aβ aggregation would be a result of cellular damage imposed by τ 
aggregation.
Risk factors and Genetics of AD
Only a minority of AD is attributable to autosomal familial AD (FAD) mutations in the 
coding sequences of AD-associated genes, such as APP and presenilin 1 (PSEN1), and this 
form of AD does not explain the more common sporadic late-onset AD (LOAD). The known 
risk factors for sporadic LOAD include age, limited education, head trauma, dietary 
cholesterol, the APOEε4 genotype, and further associations with additional proteins such as 
the insulin degrading enzyme (IDE), α2-macroglobulin and endothelin converting enzyme 2 
(ECE2) (Lahiri et al. 2003). In addition, AD risk has been associated with promoter 
polymorphisms in the APOE and APP genes (Lahiri et al. 2005; Maloney et al. 2007). 
Oxidative stress and metals in the brain and inflammatory factors are likewise linked to AD 
(Bellingham et al. 2004). Nevertheless, none of the current etiological models have proven 
sufficient to explain the sporadic nature of AD and the “incomplete” effects of known risk 
factors.
Major questions in AD can be addressed by the LEARn model
AD manifests late in adult life, however, it is not clearly understood when the disease 
actually starts and how long the biochemical events and neuropathological processes take to 
develop the disease. Is AD an early/developmental or late phenomenon? What are the factors 
that trigger the cascade of pathobiochemical processes of the disease? Thus, the major 
unresolved questions relate to the timing and nature of triggering leading to AD. Any 
unifying hypothesis to explain the etiology of AD must take into account not only 
neuropathological features but also the various environmental factors associated with AD, 
such as dietary imbalance, toxicological exposure and hormonal factors. In order to address 
the interaction of environment and genes, we have recently proposed a “Latent Early-life 
Associated Regulation” (LEARn) model, which may explain the etiology of AD, and 
possibly other neuropsychiatric and developmental disorders (Lahiri et al. 2007).
The LEARn model states that environmental agents (e.g., heavy metals), intrinsic factors 
(e.g., inflammatory cytokines), and dietary factors (e.g., folate and cholesterol) could alter 
gene regulation in a long-term fashion, beginning at early developmental stages, but that 
these perturbations do not have pathological results until significantly later in life (Basha et 
al. 2005; Lahiri et al. 2007), such as development of AD-like pathology in aged monkeys 
after infantile exposure to environmental Pb (Wu et al. 2008). It should be mentioned that 
similar hypotheses were developed in the 1980s by Barker and colleagues (Barker et al. 
2002). However, Barker's model is predicated upon low birth weight and rapid childhood 
weight gain. The LEARn model is based on the regulatory structure common to eukaryotic 
genes and the effect of methylation at certain specific sites within the promoter (regulatory) 
region of specific genes. Overall, the LEARn model based interaction is consistent with the 
classic “Barker model” of fetal origins of adult disease.
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Biochemical basis of the LEARn model
The LEARn model presumes that the foundation of latent early regulation is due to 
epigenetic modification. It combines the already-present variation of the genetic substrate 
with long-term response to differences in environmental stresses. Human DNA is most 
commonly modified by DNA methylation, which involves the addition of a methyl group to 
cytosine residues at CpG dinucleotides. This reaction is catalyzed by DNA 
methyltransferase (DNMT) enzymes. In the DNA sequence, CpG dinucleotides are found in 
clusters called CpG islands. In normal tissues, CpG islands are primarily unmethylated, and 
the aberrant methylation of CpG islands is most likely related to disease. The basis of the 
LEARn model is on changing the methylation status of a gene as hypomethylation in the 
promoter region leads to increased gene expression, whereas hypermethylation results in 
decreased gene expression. For example, environmental factors, including metals and dietary 
factors, may operate by interfering with the interaction of methylated CpG clusters with 
binding proteins, such as MeCP2 and SP1. Thus, the LEARn model uses a “promoter 
methylation” mechanism as a switch to control gene expression.
AD and the LEARn model
The LEARn model explains developmental triggering and latent expression of the APP 
gene. The APP protein and Aβ peptide appear in healthy individuals. Studies from knockout 
animals have indicated that APP has necessary functions, although there is redundancy with 
other APP protein family members. Therefore, what would trigger APP and Aβ peptides to 
be overproduced in sporadic cases of AD? The LEARn model proposes that the initial APP 
triggering mechanism activates early in life, at developmental stages. Sites of action would 
be within the promoter of APP and associated genes. The trigger is primarily a property of 
genetic regulation. It is maintained through epigenetic means, such as DNA methylation.
Other Implications of the LEARn model
The LEARn model is based on environmentally-induced hypomethylation or oxidative 
damage as the physical mechanism that perturbs gene expression (Bolin et al. 2006) (Fig. 1). 
These perturbations are latent. They are not immediately apparent in the same manner found 
in conventional toxic responses. Thus, apparent reversal of the symptoms of acute exposure 
to environmental stressors such as Pb or poor nutrition need not mean that there will be no 
long-lasting repercussions of an environmental insult. This indicates that conventional anti-
toxicity treatments may be insufficient, the relatively long term of latency suggests a 
possibility for biologically-based medical remediation. For examples, bans enacted upon 
lead (Pb) in gasoline in previous decades would significantly reduce levels of Pb in urban 
dwellers. However, the LEARn model would suggest that levels of AD would not be likely 
to decrease in response until 50-60 years after the bans were enacted, when individuals 
would begin to reach ages at risk of LOAD but would not have suffered higher levels of 
childhood Pb exposure.
On the other hand, the proposed mechanisms of LEARn, epigenetic hypomethylation and/or 
oxidative damage to DNA, do lend towards potential solutions to a LEARn-type 
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environmental exposure. For example, fruit juices, such as concentrated apple juice, have 
been shown to reverse acute oxidative damage and be a useful source of s-adenylmethionine, 
reversing hypomethylation in mice (Chan and Shea 2006). Likewise, dietary melatonin 
supplementation reduced levels of Aβ in mouse cerebral cortex (Lahiri et al. 2004). This 
suggests investigation of the use of appropriate fruit and vegetable dietary supplementation 
early in life, as a prophylactic or treatment measure against possible latent response to 
environmental insult. Thus, the LEARn model presented here has far-reaching implications 
in personal health practices and public policy.
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The LEARn Model. The LEARn model proposes a mechanism for interaction between 
genes and environment in early developmental etiology for AD. Promoter regions of genes, 
such as SP1, APP, and possibly BACE, provide the substrate for LEARn activity. 
Environmental factors such as exposure to Pb, nutritional deficiencies (e.g., folate or B12), 
or oxidative stress alter DNA epigenetically, by reducing the activity of enzymes such as 
DnMT, which would result in hypomethylation and reprogram gene expression. In some 
cases, this results in immediate alteration in gene expression levels. In LEARn systems, 
alterations are latent and effects are primarily notable later in life. In both immediate and 
LEARn systems, epigenetic changes in gene regulation result in disorder.
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